A randomized, double blind, placebo-controlled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrhea

Journal of Travel Medicine

Volumn 20, Issue 2, 2013, Pages 88-94

  Virk, Abinash ^a   Mandrekar, Jayawant ^a   Berbari, Elie F ^a   Boyce, Thomas G ^a   Fischer, Philip R ^a   Kasten, Mary J ^a   Orenstein, Robert ^b   Rosenblatt, Jon E ^a   Sampathkumar, Priya ^a   Sia, Irene ^a   Springer, Donna ^a   Witzig, Thomas E ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRI KING SYNBIOTIC; AZITHROMYCIN; CIPROFLOXACIN; LEVOFLOXACIN; LOPERAMIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; AEROMONAS; ARTICLE; BLASTOCYSTIS HOMINIS; CAMPYLOBACTER; CONSTIPATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; ENDOLIMAX NANA; FECES ANALYSIS; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SALMONELLA; SELF REPORT; TRAVEL; TRAVELLER DIARRHEA;

ADULT; ANTI-BACTERIAL AGENTS; ANTIDIARRHEALS; DIARRHEA; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG MONITORING; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOPERAMIDE; MALE; MIDDLE AGED; SYNBIOTICS; TIME FACTORS; TRAVEL; TREATMENT OUTCOME;

EID: 84874769333     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/jtm.12008     Document Type: Article

References (22)

1. Hill DR, Beeching NJ. Travelers- diarrhea. Curr Opin Infect Dis 2010; 23:481-487.
2. Pitzurra R, Steffen R, Tschopp A, Mutsch M. Diarrhoea in a large prospective cohort of European travelers to resource-limited destinations. BMC Infect Dis 2010; 10:231.
3. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32:331-351.
4. DuPont HL, Ericsson CD, Farthing MJ, et al. Expert review of the evidence base for prevention of travelers- diarrhea. J Travel Med 2009; 16:149-160.
5. Armstrong AW,Ulukan S, Weiner M, et al. Arandomized, double-blind, placebo-controlled study evaluating the efficacy and safety of rifaximin for the prevention of travelers- diarrhea in US military personnel deployed to Incirlik Air Base, Incirlik, Turkey. J Travel Med 2010; 17:392-394.
6. Flores J, Dupont HL, Jiang ZD, et al. A randomized, double-blind, pilot study of rifaximin 550mg versus placebo in the prevention of travelers- diarrhea in Mexico during the dry season. J Travel Med 2011; 18:333-336.
7. DuPont HL, Ericsson CD, Johnson PC, de la Cabada FJ. Use of bismuth subsalicylate for the prevention of travelers- diarrhea. Rev Infect Dis 1990; 12(Suppl 1):S64-S67.
8. SteffenR, HeusserR,DuPontHL. Prevention of travelers- diarrhea by nonantibiotic drugs. Rev Infect Dis 1986; 8(Suppl 2):S151-S159.
9. DuPont HL, Ericsson CD, Farthing MJ, et al. Expert review of the evidence base for self-therapy of travelers- diarrhea. J Travel Med 2009; 16:161-171.
10. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut.AmJClinNutr 1999; 69:S1052-S1057.
11. McFarland LV. Meta-analysis of probiotics for the prevention of traveler-s diarrhea. Travel Med Infect Dis 2007; 5:97-105.
12. Kollaritsch HH, Kremsner P, WiedermannG. Prevention of travelers- diarrhea: comparison of different nonantibiotic preparations. Travel Med Int 1989; 6:9-17.
13. Kollaritsch H, Holst H, Grobara P, Wiedermann G. Prevention of traveler-s diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study [German]. Fortschr Med 1993; 111:152-156.
14. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of lactobacillus GG as a diarrheal preventive in travelers. J Travel Med 1997; 4:41-43.
15. Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of travellers- diarrhoea by lactobacillus GG. Ann Med 1990; 22:53-56.
16. Katelaris PH, Salam I, Farthing MJ. Lactobacilli to prevent traveler-s diarrhea? N Engl J Med 1995; 333:1360-1361.
17. Jones RJ, Hussein HM, Zagorec M, Brightwell G, Jagg JR. Isolation of lactic acid bacteria with inhibitory activity against pathogens and spoilage organisms associated with fresh meat. Food Microbiol 2008; 25:228-234.
18. Gedek BR. Adherence of Escherichia coli serogroup O 157 and the salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 1999; 42:261-264.
19. O-Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35:549-556.
20. Briand V, Buffet P, Genty S, et al. Absence of efficacy of nonviable lactobacillus acidophilus for the prevention of traveler-s diarrhea: A randomized, doubleblind, controlled study. Clin Infect Dis 2006; 43: 1170-1175.
21. Bisson JF, Hidalgo S, Rozan P, Messaoudi M. Preventive effects of different probiotic formulations on travelers- diarrhea model in Wistar rats: preventive effects of probiotics on TD. Dig Dis Sci 2010; 55:911-919.
22. Bybee SN, Scorza AV, LappinMR. Effect of the probiotic enterococcus faecium SF68 on presence of diarrhea in cats and dogs housed in an animal shelter. J Vet Intern Med 2011; 25:856-860.